ZA91947B - Novel vaccine - Google Patents

Novel vaccine

Info

Publication number
ZA91947B
ZA91947B ZA91947A ZA91947A ZA91947B ZA 91947 B ZA91947 B ZA 91947B ZA 91947 A ZA91947 A ZA 91947A ZA 91947 A ZA91947 A ZA 91947A ZA 91947 B ZA91947 B ZA 91947B
Authority
ZA
South Africa
Prior art keywords
novel vaccine
detoxified
pertussis toxin
reversion
toxicity
Prior art date
Application number
ZA91947A
Other languages
English (en)
Inventor
Carine Capiau
Capiau Carine
Jean Petre
Petre Jean
Original Assignee
Smithkline Beecham Biolog
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Smithkline Beecham Biolog filed Critical Smithkline Beecham Biolog
Publication of ZA91947B publication Critical patent/ZA91947B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K39/099—Bordetella
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/385—Haptens or antigens, bound to carriers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/02—Bacterial antigens
    • A61K2039/10—Brucella; Bordetella, e.g. Bordetella pertussis; Not used, see subgroups

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Medicinal Chemistry (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Compounds Of Unknown Constitution (AREA)
ZA91947A 1990-02-12 1991-02-08 Novel vaccine ZA91947B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US47909890A 1990-02-12 1990-02-12

Publications (1)

Publication Number Publication Date
ZA91947B true ZA91947B (en) 1992-01-29

Family

ID=23902647

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA91947A ZA91947B (en) 1990-02-12 1991-02-08 Novel vaccine

Country Status (17)

Country Link
EP (1) EP0515415B1 (xx)
JP (1) JP3035712B2 (xx)
KR (1) KR100202052B1 (xx)
AT (1) ATE129159T1 (xx)
AU (1) AU646019B2 (xx)
CA (1) CA2075711C (xx)
CY (1) CY1935A (xx)
DE (1) DE69113991T2 (xx)
DK (1) DK0515415T3 (xx)
ES (1) ES2080941T3 (xx)
GR (1) GR3018440T3 (xx)
HK (1) HK1004524A1 (xx)
IE (1) IE70672B1 (xx)
NZ (1) NZ237069A (xx)
PT (1) PT96723B (xx)
WO (1) WO1991012020A1 (xx)
ZA (1) ZA91947B (xx)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0642355B1 (en) 1992-05-23 1998-07-15 SMITHKLINE BEECHAM BIOLOGICALS s.a. Combined vaccines comprising hepatitis b surface antigen and other antigens
GB9216351D0 (en) * 1992-07-31 1992-09-16 Wellcome Found Vaccine production
AU5441199A (en) * 1998-09-01 2000-03-21 Elan Corporation, Plc Oral vaccine compositions
AU769539B2 (en) * 1999-01-29 2004-01-29 Zoetis Services Llc Adjuvants for use in vaccines
GB0313916D0 (en) 2003-06-16 2003-07-23 Glaxosmithkline Biolog Sa Vaccine composition
WO2013113729A1 (en) 2012-02-01 2013-08-08 Glaxosmithkline Biologicals S.A. Fermentation process
US20140037680A1 (en) 2012-08-06 2014-02-06 Glaxosmithkline Biologicals, S.A. Novel method
WO2014024026A1 (en) 2012-08-06 2014-02-13 Glaxosmithkline Biologicals S.A. Method for eliciting in infants an immune response against rsv and b. pertussis
ES2597832T3 (es) 2013-03-08 2017-01-23 Janssen Vaccines & Prevention B.V. Vacuna acelular contra la tosferina
US9849066B2 (en) 2013-04-24 2017-12-26 Corning Incorporated Delamination resistant pharmaceutical glass containers containing active pharmaceutical ingredients
BE1022008B1 (fr) 2013-08-05 2016-02-03 Glaxosmithkline Biologicals S.A. Compositions immunogenes combinees

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4070454A (en) * 1973-05-04 1978-01-24 Agence Nationale De Valorisation De La Recherche (Anvar) Vaccines, the process for preparing the same and the applications thereof
JPS5750925A (en) * 1980-09-12 1982-03-25 Takeda Chem Ind Ltd Preparation of pertussis toxoid
GB8601279D0 (en) * 1986-01-20 1986-02-26 Public Health Lab Service Purification of pertussis antigens
US4888169A (en) * 1986-10-14 1989-12-19 Norden Laboratories, Inc. Bordetella Bronchiseptica vaccine
AU5027890A (en) * 1989-02-10 1990-09-05 Genesit Oy A method for producing pertussis toxin subunits

Also Published As

Publication number Publication date
CY1935A (en) 1991-02-07
DE69113991D1 (de) 1995-11-23
DE69113991T2 (de) 1996-03-21
WO1991012020A1 (en) 1991-08-22
GR3018440T3 (en) 1996-03-31
KR100202052B1 (ko) 1999-06-15
DK0515415T3 (da) 1995-11-27
KR920703099A (ko) 1992-12-17
ES2080941T3 (es) 1996-02-16
ATE129159T1 (de) 1995-11-15
AU7211091A (en) 1991-09-03
EP0515415B1 (en) 1995-10-18
CA2075711A1 (en) 1991-08-13
IE70672B1 (en) 1996-12-11
EP0515415A1 (en) 1992-12-02
NZ237069A (en) 1993-07-27
JPH05503936A (ja) 1993-06-24
PT96723A (pt) 1991-10-31
IE910424A1 (en) 1991-08-14
JP3035712B2 (ja) 2000-04-24
PT96723B (pt) 1998-07-31
HK1004524A1 (en) 1998-11-27
AU646019B2 (en) 1994-02-03
CA2075711C (en) 2000-11-07

Similar Documents

Publication Publication Date Title
DE69022106D1 (de) Pertussistoxin-Mutanten, dieselbe produzierende Bordetella-Stämme und ihre Verwendung als Vakzin gegen Pertussis.
NO165478C (no) Fremgangsmaate for fremstilling av antigeniske preparater.
ZA91947B (en) Novel vaccine
EP0276516A3 (en) New oligosaccharides, immunogens and vaccines, and methods for preparing such oligosaccharides, immunogens and vaccines
GR870917B (en) Novel mehthod of preparing toxoid
NO872919D0 (no) Fremstilling av pertussis-toksin ved dyrkning av bodella pertussis.
YU41369B (en) Process for preparing benzofurnace derivatives
CA2004206A1 (en) Method for preparing pertussis toxin toxoid
EP0338566A3 (en) Pertussis toxoid vaccine
ES2036602T3 (es) Un procedimiento de preparacion de 4'-desoxi-13(s)-dihidro-4'-yododoxorubicina.
GB2200844B (en) Preparation of bordetella bronchiseptica strains useful as vaccines
FR2601250B1 (fr) Procede de preparation de fractions antigeniques exocellulaires de bordetella pertussis et vaccin contre la coqueluche contenant de telles fractions.
CA2086258A1 (en) Pasteurella multocida toxoid vaccines
CA2312296A1 (en) Pasteurella multocida toxoid vaccines